EUVIMEDEUVIMED entdecken
Crossref

The impact of antiplatelet therapy on the descending thoracic aorta fate and long-term prognosis of extensive repaired type A aortic dissection

Bowen Zhang, Yaojun Dun, Yanxiang Liu, Jie Ren, Haoyu Gao, Luchen Wang iD, Sangyu Zhou, Mingxin Xie, Xiaogang Sun iD

European Journal of Cardio-Thoracic Surgery · 2023

DOI: 10.1093/ejcts/ezad186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2023. Verfasst von Bowen Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Uni…. Hauptthemen laut MEDLINE: Aortic Aneurysm, Thoracic, Aortic Dissection, Endovascular Procedures, Thrombosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Chinese academy of Medical Science Innovation Fund for Medical Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES To evaluate the impact of antiplatelet therapy on the long-term descending thoracic aorta (DTA) fate and prognosis of extensive repaired type A aortic dissection (TAAD). METHODS 1147 eligible TAAD patients from January 2010 to December 2019 were stratified into non-antiplatelet (n = 754) and antiplatelet groups (n = 393). The primary end points were overall survival, and DTA remodelling, including false lumen (FL) thrombosis and aortic redilation. The secondary end points were DTA reintervention or rupture and major bleeding events (MBEs). RESULTS The 5-year overall survival rates were 95.6% and 94.3% in the non-antiplatelet and antiplatelet groups (P = 0.53), respectively. In the stent covering segment, the 1-year FL complete thrombosis rates were 92.1% and 92.4% in the non-antiplatelet and antiplatelet groups (P = 0.27), respectively, while in the stent uncovering segment, the 5-year FL complete thrombosis rates were 47.1% and 56.5% in the non-antiplatelet and antiplatelet groups (P = 0.12), respectively. Antiplatelet therapy was not an independent predictor of aortic redilation at the pulmonary artery bifurcation (β±SE = –0.128 ± 0.203, P = 0.53), diaphragm (β±SE = 0.143 ± 0.152, P = 0.35) or coeliac artery (β±SE = 0.049 ± 0.136, P = 0.72) levels. With death as a competing risk, the cumulative incidences of DTA reintervention or rupture at 5 years were 4.6% and 4.0% in the non-antiplatelet and antiplatelet groups (sHR = 0.85, 95% CI, 0.49∼1.19; P = 0.58), respectively, and the 5-year cumulative incidences of MBEs were 2.1% and 2.3% in the non-antiplatelet and antiplatelet groups (sHR = 0.82, 95% CI, 0.56∼2.67; P = 0.62), respectively. CONCLUSIONS Antiplatelet therapy did not impact long-term DTA FL thrombosis, redilation, reintervention or rupture, MBEs or overall survival on extensive repaired TAAD. Thus, antiplatelet therapy can be administered as indicated on extensive repaired TAAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Aneurysm, ThoracicAortic DissectionEndovascular ProceduresThrombosisBlood Vessel Prosthesis ImplantationHumansAorta, ThoracicTreatment OutcomePrognosisRetrospective StudiesStentsAzidesDeoxyglucose

Stichwörter der Autor:innen

AntiplateletDescending thoracic aorta fateExtensive arch repairFalse lumen thrombosisType A aortic dissection

Substanzen

1,3,4,6-tetra-O-acetyl-2-azido-2-deoxyglucopyranoseAzidesDeoxyglucose

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

ORCID-Profile: Luchen Wang, Xiaogang Sun

Förderung

  • Chinese academy of Medical Science Innovation Fund for Medical Science

Zitieren

APA

Zhang, B., Dun, Y., Liu, Y., Ren, J., Gao, H., Wang, L., Zhou, S., Xie, M., & Sun, X. (2023). The impact of antiplatelet therapy on the descending thoracic aorta fate and long-term prognosis of extensive repaired type A aortic dissection. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezad186

Vancouver

Zhang B, Dun Y, Liu Y, Ren J, Gao H, Wang L, et al. The impact of antiplatelet therapy on the descending thoracic aorta fate and long-term prognosis of extensive repaired type A aortic dissection. European Journal of Cardio-Thoracic Surgery. 2023. doi:10.1093/ejcts/ezad186

BibTeX
@article{Zhang2023,
  author = {Zhang, Bowen and Dun, Yaojun and Liu, Yanxiang and Ren, Jie and Gao, Haoyu and Wang, Luchen and Zhou, Sangyu and Xie, Mingxin and Sun, Xiaogang},
  title = {The impact of antiplatelet therapy on the descending thoracic aorta fate and long-term prognosis of extensive repaired type A aortic dissection},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2023},
  doi = {10.1093/ejcts/ezad186}
}
Kostenlos starten →